Chinese Herbal Medicine for Menopausal Symptoms: A Systematic Review and Meta-Analysis

This section explains the research question in plain language. It is not a medical interpretation or treatment recommendation.

Menopause is a natural biological transition, yet the accompanying symptoms — particularly hot flashes and night sweats — can substantially affect quality of life, sleep, mood, and daily functioning. While hormone replacement therapy (HRT) is effective for many women, concerns about contraindications, side effects, and personal preferences lead some to explore complementary and traditional approaches.

In Traditional Chinese Medicine, the menopausal transition has been addressed for centuries through herbal formulas aimed at nourishing Yin, balancing Kidney function, and calming the Spirit. Despite this long traditional history, the modern clinical evidence base for Chinese herbal medicine (CHM) in menopausal symptoms has remained fragmented and difficult to interpret.

This systematic review and meta-analysis, published in Menopause in 2015, set out to answer a focused question: what does the available randomized controlled trial evidence suggest about the efficacy and safety of CHM for menopausal symptoms, particularly hot flashes? The authors searched multiple electronic databases, hand-searched reference lists, and contacted authors where necessary to identify all relevant RCTs. Their goal was to provide a comprehensive, critical synthesis of the evidence landscape.

Understanding how this review was conducted is essential for interpreting what its findings mean — and how much weight they should carry.

Inclusion and Exclusion Criteria

The authors included randomized controlled trials (RCTs) that compared Chinese herbal medicine (as a sole intervention) against placebo, no treatment, or conventional therapy in women experiencing menopausal symptoms. Trials had to report at least one objective or subjective outcome related to hot flashes, night sweats, or overall menopausal symptom scores. Studies combining acupuncture with herbal medicine, or using non-Chinese herbal preparations, were excluded. Animal studies and in vitro experiments were also excluded.

Search Strategy

The authors searched PubMed/MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), CINAHL, and major Chinese-language databases including CNKI and Wanfang. They used combinations of keywords such as "Chinese herbal medicine," "traditional Chinese medicine," "menopause," "hot flashes," "climacteric," and "randomized controlled trial." No language restrictions were applied initially, though only trials with sufficient data for extraction were retained. Reference lists of included studies and relevant reviews were hand-searched to identify additional trials.

Data Extraction and Quality Assessment

Two reviewers independently extracted data on study characteristics, participant demographics, interventions, outcomes, and adverse events. The Cochrane Risk of Bias tool was used to assess each included trial across domains including random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias. Disagreements were resolved through discussion or consultation with a third reviewer.

Statistical Analysis

Where appropriate, data were pooled using random-effects meta-analysis to account for expected clinical and methodological heterogeneity. Dichotomous outcomes were expressed as risk ratios (RR) with 95% confidence intervals; continuous outcomes were expressed as mean differences (MD) or standardized mean differences (SMD) with 95% confidence intervals. Heterogeneity was assessed using the I² statistic. Subgroup analyses and sensitivity analyses were planned to explore sources of heterogeneity, though the small number of trials limited the robustness of these explorations.

The review identified twelve RCTs meeting the inclusion criteria. The total number of participants ranged from approximately 1,200 to 1,500 women, though exact numbers varied depending on the outcome analyzed due to incomplete reporting in some trials.

Hot Flash Frequency and Severity

The primary outcome of interest was the effect of CHM on hot flash frequency and severity. In pooled analyses, CHM was associated with a reduction in hot flash frequency compared with placebo, and some trials also reported reductions in hot flash severity. The effect sizes were modest to moderate, but the confidence intervals were wide and statistical heterogeneity was substantial (I² values often exceeding 50%). This heterogeneity suggests that the true effect may vary considerably depending on the specific formula used, the population studied, and the methodological quality of individual trials.

Overall Menopausal Symptom Scores

Several trials used the Kupperman Index (KI) or the Menopause-Specific Quality of Life (MENQOL) questionnaire to assess overall symptom burden. Pooled results suggested a statistically significant improvement in KI scores favoring CHM over placebo. However, the clinical significance of this improvement — whether women would perceive a meaningful difference in daily life — was less clear. The authors noted that the minimal clinically important difference for the Kupperman Index in this context has not been firmly established.

Safety and Adverse Events

Adverse events reported across the included trials were generally mild and infrequent. The most commonly reported events were gastrointestinal discomfort (nausea, bloating, loose stools), mild skin reactions, and altered taste. No serious adverse events were attributed to CHM in the included trials. However, the authors appropriately cautioned that the small sample sizes and relatively short treatment durations (most trials lasted 4 to 12 weeks) meant that rare adverse events or long-term safety concerns could not be adequately assessed.

Every systematic review is only as strong as the studies it includes. Here, the evidence base had several important cracks.

• Small sample sizes — Most included trials enrolled fewer than 150 participants, and several had fewer than 60. Small trials are more susceptible to random error and may produce inflated effect estimates.
• Inadequate blinding — Many trials were described as "open-label" or did not clearly report blinding procedures. Unblinded trials of subjective outcomes such as hot flashes are prone to placebo effects and performance bias, which tend to exaggerate treatment benefits.
• Variable interventions — The herbal formulas studied differed substantially in composition, dosage form (raw decoction, concentrated granules, capsules), and treatment duration. This clinical heterogeneity limits the ability to identify which specific herbs or formulas may be associated with any observed effects.
• Inconsistent outcome measurement — Different trials used different symptom scales, diaries, and assessment time points. Some used validated instruments; others used unvalidated or author-designed questionnaires. This inconsistency complicates meaningful pooling and interpretation.
• Risk of publication bias — As with many areas of TCM research, there is concern that small negative trials may remain unpublished, particularly in Chinese-language journals. The authors noted that funnel plot asymmetry could not be reliably assessed due to the small number of trials.
• Short follow-up — Most trials assessed outcomes over 4 to 12 weeks. Whether any benefits persist with longer use, and whether longer-term safety remains acceptable, is unknown.

These limitations do not render the review meaningless. They frame its conclusions appropriately: the evidence suggests a potential signal worth investigating further, not a definitive endorsement of CHM for menopausal symptoms.

This section provides traditional TCM context. It is an educational framework, not a medical diagnosis or treatment recommendation.

In Traditional Chinese Medicine, the menopausal transition is understood through the lens of declining Kidney essence (Jing), particularly Kidney Yin. The Kidneys are considered the root of congenital essence and govern growth, development, and reproduction. As Kidney Yin declines with age, the balance between Yin and Yang shifts, often leading to a relative excess of Yang or Empty Fire. This imbalance manifests in symptoms such as hot flashes, night sweats, restlessness, and insomnia.

TCM pattern differentiation (Bian Zheng) for menopausal symptoms commonly identifies several patterns:

• Kidney Yin deficiency (肾阴虚) — The most commonly encountered pattern, characterized by hot flashes, night sweats, five-center heat ( palms, soles, chest), dizziness, tinnitus, dry mouth, and a red tongue with little coating.
• Kidney Yang deficiency (肾阳虚) — Characterized by cold intolerance, cold limbs, edema, low libido, frequent urination, and a pale, swollen tongue.
• Kidney Yin and Yang both deficient (肾阴阳两虚) — A mixed pattern with alternating heat and cold signs, fatigue, and weakness.
• Liver and Kidney Yin deficiency (肝肾阴虚) — Accompanied by blurred vision, dry eyes, irritability, and dizziness.
• Heart and Kidney not communicating (心肾不交) — Manifesting as insomnia, restlessness, palpitations, and anxiety alongside Yin deficiency signs.

The principle of TCM treatment for menopausal symptoms is not to administer a single standardized formula to all women, but to tailor the herbal prescription to the individual's pattern. This individualized approach is a hallmark of TCM practice, but it also creates challenges for clinical research, where standardized interventions are preferred for reproducibility.

For more information about menopause from a TCM perspective, visit our Women's Health topic hub.

Safety considerations are paramount when discussing any intervention for menopausal symptoms, given the chronic nature of the condition and the potential for herb-drug interactions.

• Herb-drug interactions — Some herbs commonly used in menopausal formulas may interact with anticoagulants, antiplatelet agents, sedatives, or diabetes medications. For example, Dang Gui (Angelica sinensis) contains coumarins and may potentiate the effect of warfarin. Women taking prescription medications should consult a qualified practitioner and inform their conventional healthcare provider before using herbal products.
• Hormone-sensitive conditions — Some herbs contain phytoestrogens or compounds with weak estrogenic activity. Women with a history of hormone-dependent cancers (e.g., estrogen receptor-positive breast cancer) should exercise particular caution and discuss any herbal use with their oncology team.
• Product quality — The safety of CHM depends heavily on product quality, including correct identification of herbs, absence of contaminants (heavy metals, pesticides, adulterants), and accurate labeling. Quality varies widely across products and jurisdictions.
• Self-diagnosis risk — TCM pattern differentiation requires professional training. Self-prescribing based on symptom descriptions carries the risk of choosing an inappropriate formula, which may be ineffective or, in some cases, counterproductive.
• Not a substitute for medical care — Menopausal symptoms can overlap with symptoms of thyroid disorders, cardiovascular disease, depression, and other conditions that require medical evaluation. CHM should not be used to delay or replace appropriate medical assessment and conventional treatment when indicated.

These entities are linked for educational reference. Their inclusion does not constitute treatment recommendations.

Key Herbs Traditionally Associated with Menopausal Patterns

Related Formulas

• Liu Wei Di Huang Wan (六味地黄丸, Six-Ingredient Rehmannia Pill) — The classical Kidney Yin tonic, consisting of Shu Di Huang, Shan Zhu Yu, Shan Yao, Ze Xie, Mu Dan Pi, and Fu Ling. One of the most commonly studied formulas in menopause trials.
• Zhi Bai Di Huang Wan (知柏地黄丸, Anemarrhena, Phellodendron, and Rehmannia Pill) — Liu Wei Di Huang Wan plus Zhi Mu and Huang Bai, traditionally indicated for Kidney Yin deficiency with Empty Fire and night sweats.
• Tian Wang Bu Xin Dan (天王补心丹, Emperor of Heaven's Special Pill to Tonify the Heart) — For Heart and Kidney Yin deficiency with insomnia, palpitations, and restlessness.
• Gan Mai Da Zao Tang (甘麦大枣汤, Licorice, Wheat, and Jujube Decoction) — A gentle formula traditionally used to nourish the Heart and calm the Spirit, particularly for emotional lability, sadness, and anxiety.
• Xiao Yao San (逍遥散, Free and Easy Wanderer) — For Liver Qi stagnation with Blood deficiency, often relevant for mood swings, irritability, and stress-aggravated symptoms.

Related Symptoms and Conditions

• Hot Flashes — Detailed information about this common vasomotor symptom, its triggers, and TCM perspectives.
• Night Sweats — Information about nocturnal sweating and its traditional associations.
• Insomnia — Sleep disturbances during menopause and TCM frameworks for understanding them.
• Women's Health — A comprehensive topic hub covering TCM approaches to gynecological and women's health conditions.